GRAS Notices
-
GRN No. 660
Bacillus coagulans GBI-30, 6086 spores
Intended Use: | Ingredient in non-exempt powdered and liquid infant formulas for term infants (infant formula) at levels up to 2 x 10^8 colony forming units (CFU) per 100 milliliters (mL) infant formula as consumed. |
---|---|
Basis: | Scientific procedures |
Notifier: | Ganeden Biotech, Inc. |
Notifier Address: | 5800 Landerbrook Drive, Suite 300; Mayfield Heights, Ohio 44124 |
Date of filing: | Aug 16, 2016 |
GRAS Notice (releasable information): | GRN 660 (in PDF)6 (3.6 MB) |
Date of closure: | Jan 13, 2017 |
FDA's Letter: | FDA has no questions (in PDF)7 (81 kB) |
Notes: | Infant formula uses. Same strain as GRN 399, though not a spore, and for use in infant formula (not covered in GRN 399): GRN 3998 |
-